Expression of p53 protein in T- and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations
- 1 February 2001
- journal article
- Published by Elsevier in Human Pathology
- Vol. 32 (2) , 196-204
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- The p53 pathwayThe Journal of Pathology, 1999
- Multiple pathways control cell growth and transformation: overlapping and independent activities of p53 and p21Cip1/WAF1/Sdi1The Journal of Pathology, 1997
- Mutations of the p53 Gene as a Prognostic Factor in Aggressive B-Cell LymphomaNew England Journal of Medicine, 1997
- A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's LymphomaBlood, 1997
- p21WAF1/CIP1 AND MDM2 EXPRESSION IN NON-HODGKIN'S LYMPHOMA AND THEIR RELATIONSHIP TO p53 STATUS: A p53+, MDM2−, p21− IMMUNOPHENOTYPE ASSOCIATED WITH MISSENSE p53 MUTATIONSThe Journal of Pathology, 1997
- p53 in hematologic malignanciesBlood, 1994
- A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]Blood, 1994
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- p53 mutation is associated with progression in follicular lymphomasBlood, 1993
- p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia.Proceedings of the National Academy of Sciences, 1991